Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results-Reference-Cited by-同舟云学术

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Published:2014-12-24 Issue:4 Volume:30 Page:500-509
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Fernandez Hubert H.¹,Standaert David G.²,Hauser Robert A.³,Lang Anthony E.⁴,Fung Victor S.C.⁵,Klostermann Fabian⁶,Lew Mark F.⁷,Odin Per⁸,Steiger Malcolm⁹,Yakupov Eduard Z.¹⁰,Chouinard Sylvain¹¹,Suchowersky Oksana¹²,Dubow Jordan¹³,Hall Coleen M.¹³,Chatamra Krai¹³,Robieson Weining Z.¹³,Benesh Janet A.¹³,Espay Alberto J.¹⁴

Affiliation:

1. Center for Neurological RestorationCleveland ClinicCleveland Ohio USA

2. University of Alabama at BirminghamBirmingham Alabama USA

3. Department of NeurologyUniversity of South FloridaTampa Florida USA

4. University of TorontoToronto Ontario Canada

5. Movement Disorders UnitWestmead Hospital and Sydney Medical School Sydney Australia

6. Charité‐University Medicine Berlin Berlin Germany

7. Keck/USC School of MedicineLos Angeles California USA

8. Klinikum‐Bremerhaven, Bremerhaven, Germany and Skane University Hospital Lund Sweden

9. Walton Center for Neurology and Neurosurgery Liverpool United Kingdom

10. Kazan State Medical UniversityKazan Russia

11. University of MontrealMontreal Quebec Canada